Cushing Triad, also known as the Cushing reflex, is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The triad is named after Harvey Cushing, an American neurosurgeon who first described the condition in 1932. This article provides a comprehensive overview of Cushing Triad, including its diagnosis and treatment.
The diagnosis of Cushing Triad is based on the presence of three clinical signs: hypertension, bradycardia, and an irregular respiratory rate. Hypertension is defined as a systolic blood pressure greater than 150 mmHg and/or a diastolic blood pressure greater than 90 mmHg. Bradycardia is defined as a heart rate less than 60 beats per minute. An irregular respiratory rate is defined as an increase in the respiratory rate of more than 10 breaths per minute or a decrease in the respiratory rate of more than 10 breaths per minute. The diagnosis of Cushing Triad is usually made based on the presence of these three clinical signs. However, in some cases, additional tests may be necessary to confirm the diagnosis. These tests may include computed tomography (CT) or magnetic resonance imaging (MRI) scans of the head, a lumbar puncture to measure the intracranial pressure, and/or an electroencephalogram (EEG) to measure brain activity.
Cushing Triad is most commonly associated with increased intracranial pressure (ICP) due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. Other causes of Cushing Triad include meningitis, subarachnoid hemorrhage, and intracranial hypertension due to drug toxicity or metabolic disorders.
The treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure. This may include surgery to remove the tumor or hematoma, or to relieve pressure on the brain. Other treatments may include medications to reduce the pressure, such as diuretics, corticosteroids, and osmotic agents. In some cases, treatment may also include the use of a ventriculostomy, which is a procedure in which a small hole is made in the skull to relieve pressure on the brain. Finally, in some cases, treatment may include the use of a shunt, which is a device that is surgically implanted to divert excess cerebrospinal fluid away from the brain.
Cushing Triad is a medical condition characterized by a combination of three signs: hypertension, bradycardia, and an irregular respiratory rate. It is most commonly associated with increased intracranial pressure due to a variety of causes, including traumatic brain injury, brain tumors, hydrocephalus, and intracranial hematomas. The diagnosis of Cushing Triad is based on the presence of these three clinical signs, and additional tests may be necessary to confirm the diagnosis. Treatment of Cushing Triad is aimed at reducing the underlying cause of the increased intracranial pressure, and may include surgery, medications, a ventriculostomy, or a shunt.
1.
Reducing social media to an hour a day boosts young people's self-image.
2.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
3.
The pandemic had little impact on mental health symptoms.
4.
FDA Approves New Bladder Cancer First-Line Standard of Care.
5.
A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.
1.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
2.
Ferroptosis-Modulating Nanocarriers for Solid Tumor Therapy
3.
Long-Term Wellness After Childhood Cancer Therapy
4.
Innate Lymphoid Cells in Tumor Biology
5.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation